| Title |
Author |
Type |
Date |
Words |
| Breast milk antibodies help neutralize HIV. |
|
|
May 23, 2012 |
464 |
| HIV Vaccine Trials Network Opens Enrollment for Phase 1 Trial of GeoVax Labs' Second Generation HIV Vaccine. |
|
|
May 22, 2012 |
1174 |
| NIH statement on HIV Vaccine Awareness Day - May 18, 2012. |
|
|
May 14, 2012 |
102 |
| IAVI, GlycoMimetics, and Glycosensors and Diagnostics Collaborate to Develop Novel AIDS Vaccine Candidate. |
|
|
May 9, 2012 |
815 |
| Attend BIO tech 2012 Conference to Grab the Latest Trends on "Vaccines", Whose Market is Greatly Expanding. - Asia's Largest Bio Event. |
|
Conference news |
Apr 10, 2012 |
796 |
| Leading Global Health Expert Dr. Adel A.F. Mahmoud Joins IAVI Board of Directors. |
|
|
Apr 9, 2012 |
715 |
| Possible clues found to why HIV vaccine showed modest protection. |
|
|
Apr 5, 2012 |
157 |
| AIDS vaccine testing on humans. |
|
|
Apr 1, 2012 |
260 |
| Bacterial polysaccharide could lead to HIV vaccine. |
Irving, Tyler |
|
Apr 1, 2012 |
409 |
| Cuba: AIDS vaccine testing on humans? |
|
|
Apr 1, 2012 |
341 |
| PX'Therapeutics Announces EuroNeut-41 Prophylactic HIV Vaccine Clinical Trial. |
|
|
Mar 12, 2012 |
329 |
| Effective vaccine against HIV/AIDS comes closer to reality. |
|
|
Mar 8, 2012 |
487 |
| Effective HIV vaccines come closer to reality. |
|
|
Jan 5, 2012 |
356 |
| First Human Volunteer Immunized in Clinical Trial of Profectus BioSciences' Vesicular Stomatitis Virus-vectored HIV-1 Vaccine. |
|
|
Jan 4, 2012 |
879 |
| Human Trials Initiated for New HIV Vaccine. |
|
|
Dec 21, 2011 |
723 |
| Nearly 90 Medicines and Vaccines In Development for HIV/AIDS. |
|
|
Dec 1, 2011 |
565 |
| Johnson & Johnson turns its back on poor people with HIV. |
Harvey, Nick |
|
Dec 1, 2011 |
483 |
| Top 10 Myths About HIV Vaccine Research (Dec. 1 is World Aids Day). |
|
|
Nov 18, 2011 |
1487 |
| Research and Markets: Competitor Analysis: HIV Vaccines. |
|
|
Nov 7, 2011 |
296 |
| Mary Tydings, Managing Director at Russell Reynolds Associates, Joins IAVI Board. |
|
|
Nov 1, 2011 |
742 |
| GeoVax Phase 2a Clinical Trial Completes Enrollment. |
|
|
Oct 3, 2011 |
1010 |
| Altered HIV cuts its ability to suppress immune system. |
|
|
Sep 29, 2011 |
247 |
| HIV VACCINE HOPE AFTER NEW TRIALS. |
|
|
Sep 29, 2011 |
198 |
| GeoVax Labs' CSO and Chairman Receive Academic Honors. |
|
|
Sep 29, 2011 |
790 |
| Inovio Pharmaceuticals Completes PENNVAX(TM)-B HIV Vaccine Phase I Study, Demonstrates Best-in-Class T-Cell Immune Responses. |
|
|
Sep 14, 2011 |
1735 |
| Inovio Pharmaceuticals to Present at Scientific Conferences. |
|
Conference news |
Sep 7, 2011 |
1111 |
| GeoVax $3.6 Million Award Increased to $4.4 Million by U.S. Government. |
|
|
Sep 1, 2011 |
720 |
| Novel antibodies capable of blocking HIV infection isolated. |
|
|
Aug 18, 2011 |
248 |
| AIDS Researchers Isolate New Potent and Broadly Effective Antibodies Against HIV. |
|
|
Aug 17, 2011 |
1691 |
| GeoVax Awarded $3.6 Million Grant by U.S. Government for its HIV/AIDS Vaccine Program. |
|
|
Aug 16, 2011 |
796 |
| NIH-Led Team Maps Route for Eliciting HIV Neutralizing Antibodies. |
|
Brief article |
Aug 11, 2011 |
133 |
| HIV vaccine a priority, even if partially effective. |
Smith, Jennie |
|
Aug 1, 2011 |
616 |
| SEEK Announces Clinical Proof of Efficacy in HIV Vaccine Phase Ib/II Human Trial. |
|
|
Jul 18, 2011 |
1708 |
| A new battlefront: . |
Thaler, Sebastian |
|
Jul 1, 2011 |
2364 |
| ViroStatics CEO Franco Lori, MD to Present Novel Immune-based Technologies for HIV/AIDS and Chronic Diseases at the 2011 BIO International Conference. |
|
Conference news |
Jun 27, 2011 |
511 |
| GeoVax Initiates Third Site For Therapeutic Testing of Its HIV Vaccine. |
|
|
Jun 23, 2011 |
1046 |
| Scientists Launch Vaccine Research Foundation. |
|
|
Jun 8, 2011 |
1986 |
| Scientists Launch Vaccine Research Foundation. |
|
|
Jun 8, 2011 |
2027 |
| Profectus BioSciences Announces Initiation of Phase I Clinical Trial to Evaluate Safety and Immunogenicity of a Vesicular Stomatitis Virus-vectored HIV-1 Vaccine. |
|
|
Jun 1, 2011 |
741 |
| Scientists envisage vaccines for malaria, TB, HIV/AIDS by 2020. |
|
|
May 26, 2011 |
453 |
| The ACTG Immunizes First Subject in Clinical Trial of Profectus BioSciences' Therapeutic HIV DNA Vaccine. |
|
|
May 25, 2011 |
996 |
| Study shows promise for preventive vaccine against HIV/AIDS. |
|
|
May 24, 2011 |
251 |
| On HIV Vaccine Awareness Day AVAC Calls For Continued Commitment to HIV Vaccine Research. |
|
|
May 18, 2011 |
715 |
| Article by GeoVax Labs CSO Featured in The Scientist. |
|
|
May 13, 2011 |
743 |
| VACCINE TO 'WIPE OUT' AIDS VIRUS; Jab left no trace of HIV after 1 year. |
|
|
May 12, 2011 |
411 |
| VACCINE TO 'WIPE OUT' AIDS VIRUS; Jab left no trace of HIV after 1 year. |
|
|
May 12, 2011 |
374 |
| MONKEY VACCINE HOPE FOR HIV CURE; Sick animals recover. |
|
|
May 12, 2011 |
317 |
| Hope for millions after new AIDS vaccine 'removed all traces of disease in monkeys'. |
|
|
May 12, 2011 |
410 |
| National HIV Vaccine Awareness Day May 18, 2011. |
|
|
May 11, 2011 |
117 |
| Consortium Awards $23.4 Million for Promising HIV/AIDS Preventive Vaccine Candidate Developed by Institute of Human Virology at the University of Maryland School of Medicine. |
|
|
May 5, 2011 |
1123 |
| Expansion of HIV/AIDS Vaccine Program Announced by GeoVax Labs, Inc. |
|
|
Apr 11, 2011 |
1123 |
| GeoVax Labs HIV/AIDS Vaccine Development Leadership to be Highlighted During 2011 World Vaccine Congress. |
|
|
Apr 7, 2011 |
843 |
| Promising target for AIDS vaccine identified. |
|
|
Apr 1, 2011 |
413 |
| Criminalizing HIV transmission and exposure in Canada: a public health evaluation. |
Drummond, Sarah L. |
|
Mar 22, 2011 |
6608 |
| THSTI,IAVI announce new HIV vaccine design program in India. |
|
|
Mar 5, 2011 |
503 |
| HIV vaccine design program launched in India. |
|
|
Mar 4, 2011 |
476 |
| GEOVAX LABS REPORTS A 2010 4TH QTR NET LOSS OF $478,784. |
|
Financial report |
Mar 1, 2011 |
1237 |
| GeoVax Announces Publication of Phase 1 Clinical Trial in The Journal of Infectious Diseases. |
|
|
Feb 23, 2011 |
1257 |
| GeoVax Launches a Second Clinical Site to Test the Therapeutic Benefit of its HIV Vaccine. |
|
|
Feb 9, 2011 |
1017 |
| GeoVax Labs CSO Dr. Harriet L. Robinson to be Honored at 2011 Georgia Bio (GaBio) Community Awards Ceremony. |
|
|
Jan 20, 2011 |
1065 |
| New findings bring scientists closer to an effective HIV vaccine. |
|
|
Jan 15, 2011 |
246 |
| Inovio Pharmaceuticals' Novel DNA Vaccine for Clade C HIV Achieves Immune Responses and Protection in Non-Human Primates. |
|
|
Jan 10, 2011 |
1200 |
| Profectus BioSciences Announces Initiation of Clinical Trial of IL-12 Enhanced Therapeutic HIV DNA Vaccine Delivered Using Electroporation. |
|
|
Jan 5, 2011 |
965 |
| Profectus Biosciences' GENEVAX IL-12 Adjuvant Significantly Improves pDNA Vaccine Performance in Phase I Human Trial. |
|
|
Dec 14, 2010 |
1164 |
| Genetic Immunity Presents the DermaPrep Transdermal Delivery System and DermaVir Nanomedicine-based Therapeutic Vaccine for HIV/AIDS at HIV DART 2010 Drug Development Conference. |
|
Conference news |
Dec 9, 2010 |
439 |
| VIRxSYS Presents New Therapeutic Vaccine Data at HIV DART 2010. |
|
|
Dec 8, 2010 |
541 |
| GeoVax Announces Expansion of Phase 2a Human HIV/AIDS Vaccine Trial. |
|
|
Dec 6, 2010 |
959 |
| 100 Medicines and Vaccines in Development for HIV/AIDS. |
|
|
Nov 30, 2010 |
908 |
| Designing More Effective Anti-HIV Antibodies. |
|
|
Nov 19, 2010 |
1088 |
| Inovio Pharmaceuticals' HIV DNA Vaccine Achieves Strong T-Cell Immune Responses in Phase I Human Trial. |
|
|
Nov 17, 2010 |
1610 |
| Inovio Pharmaceuticals HIV Study Update to be Presented at HVTN Conference. |
|
Clinical report |
Nov 12, 2010 |
888 |
| GeoVax Awarded Federal Grant Under the Qualifying Therapeutic Discovery Project Program. |
|
|
Nov 4, 2010 |
886 |
| Article by GeoVax Labs CEO Featured in October 15 Issue of Genetic Engineering & Biotechnology News. |
|
|
Oct 18, 2010 |
823 |
| GeoVax Labs Announces Issuance of 6th Patent. |
|
|
Oct 7, 2010 |
1036 |
| Mack-Cali signs headquarters lease with international AIDS organization. |
|
|
Oct 6, 2010 |
171 |
| GenVec Receives Second-Year Funding From SAIC for HIV and Influenza Vaccine Development. |
|
|
Oct 6, 2010 |
741 |
| Profectus BioSciences, Inc. Receives $4.4M in Grants to Develop an HIV Prophylactic Vaccine. |
|
|
Oct 5, 2010 |
491 |
| Altravax, Inc. Awarded $1.2 Million in Federal Funds for Vaccines for HIV/AIDS. |
|
|
Oct 5, 2010 |
415 |
| VIRxSYS Corporation Demonstrates "Functional Cure" and Survival Benefit for the simian model of HIV in Preclinical Vaccine Study. |
|
|
Oct 1, 2010 |
530 |
| GeoVax Presents at AIDS Vaccine 2010 Conference in Atlanta. |
|
|
Oct 1, 2010 |
1336 |
| Mack-Cali Announces NYC Headquarters Lease With International AIDS Vaccine Organization. |
|
|
Sep 30, 2010 |
705 |
| Novel discoveries offer new ways to design HIV vaccine. |
|
|
Sep 30, 2010 |
547 |
| Inovio Pharmaceuticals' HIV DNA Vaccine/Electroporation Delivery Technology Selected for NIH-Sponsored U.S. Army Human Clinical Trial. |
|
|
Sep 28, 2010 |
1747 |
| Biojector[R]2000 Utilized in a Human Clinical Trial of DNA-MVA HIV Vaccine. |
|
|
Sep 28, 2010 |
727 |
| New approach to fight HIV could spur vaccine development. |
|
|
Sep 28, 2010 |
353 |
| IAVI-Led Team Wins Major Grant to Study HIV-Neutralizing Antibodies. |
|
|
Sep 27, 2010 |
1150 |
| GeoVax to Present at Aids Vaccine 2010 Conference in Atlanta. |
|
Conference news |
Sep 27, 2010 |
1342 |
| Biomedical approaches to HIV prevention. |
Mayer, Kenneth H.; Skeer, Margie; Mimiaga, Matthew J. |
Report |
Sep 22, 2010 |
7385 |
| Inovio Completes Enrollment of HIV Clinical Trial for DNA Vaccine Delivered Using Electroporation. |
|
Clinical report |
Sep 21, 2010 |
952 |
| CytoGenix, Inc. Announces Expansion of Its Advisory Board. |
|
|
Sep 9, 2010 |
705 |
| GeoVax Labs to Present at the Rodman & Renshaw 12th Annual Healthcare Conference. |
|
Conference news |
Sep 7, 2010 |
889 |
| AVAC Calls for AIDS Vaccine Field to Implement New Scientific Strategic Plan Released by Global HIV Vaccine Enterprise. |
|
|
Sep 7, 2010 |
751 |
| Senior Merck Executive to Head IAVI's AIDS Vaccine Design and Development Laboratory. |
|
|
Aug 10, 2010 |
842 |
| Safety & immunogenicity of tgAAC09, a recombinant adeno-associated virus type 2 HIV-1 subtype C vaccine in India. |
Mehendale, Sanjay; Sahay, Seema; Thakar, Madhuri; Sahasrabuddhe, Sushant; Kakade, Meghana; Shete, As |
Report |
Aug 1, 2010 |
5157 |
| Three antibodies shown to block HIV: find may suggest new, if challenging, path to AIDS vaccine. |
Seppa, Nathan |
|
Jul 31, 2010 |
488 |
| GeoVax's Chief Scientific Officer Interviewed on HealthRadio.net. |
|
|
Jul 22, 2010 |
1181 |
| Report Warns Flat Global Funding for HIV Prevention Research May Limit Ability of Researchers to Move Promising Approaches Forward. |
|
Report |
Jul 20, 2010 |
1337 |
| Abzyme Research Foundation Announces Promising HIV Vaccine Candidate. |
|
|
Jul 20, 2010 |
864 |
| Immunacia's Genetic Immunity Reports Phase II Data on DermaVir, a Therapeutic Vaccine for HIV/AIDS, During the XVIII International AIDS Conference: A 70% Viral Load Reduction Demonstrated in HIV Drug-naove Individuals. |
|
Conference news |
Jul 19, 2010 |
687 |
| An AIDS vaccine may be one step closer after scientists found antibodies in the blood of a patient that kill more than 90% of HIV strains, according to a study in the journal Science. |
|
|
Jul 12, 2010 |
559 |
| Immunacia's Genetic Immunity Presents DermaVir at the 7th International Conference on Nanosciences & Nanotechnologies - A Unique Nanomedicine for Therapeutic HIV Vaccine. |
|
Conference notes |
Jul 12, 2010 |
539 |
| HIV antibody discovery small step toward vaccine. |
|
|
Jul 12, 2010 |
448 |
| Scientists Find Promising Method to Prevent, Treat HIV Infection. |
|
|
Jul 10, 2010 |
863 |
| Antibodies that prevent 90pct of HIV strains from infecting humans discovered. |
|
|
Jul 9, 2010 |
383 |
| AIDS vaccine eyed from HIV antibodies. |
|
|
Jul 8, 2010 |
199 |
| Margaret McGlynn, Former President of Global Vaccines at Merck, Joins IAVI Board. |
|
|
Jul 6, 2010 |
782 |
| Historic HIV Vaccine Trial Involving GeoVax Vaccine Spotlighted in The Georgia Voice and The Body. |
|
|
Jul 2, 2010 |
971 |
| ARCA LAUNCHES THERAPEUTIC TRIAL WITH GEOVAX VACCINE. |
|
|
Jun 29, 2010 |
806 |
| Japan Contributes $10 Million for AIDS Vaccine Development. |
|
|
Jun 28, 2010 |
682 |
| Immunity glitch keeps HIV at bay: discovery could be helpful in future vaccine development. |
Saey, Tina Hesman |
Brief article |
Jun 5, 2010 |
322 |
| Inovio Pharmaceuticals to Present at Investor Conferences. |
|
Conference news |
Jun 2, 2010 |
605 |
| ARCA Launches First Therapeutic Trial with GeoVax Vaccine. |
|
|
May 27, 2010 |
1248 |
| GeoVax Labs Spotlighted on Inc. Magazine Website. |
|
|
May 20, 2010 |
915 |
| GeoVax to Present at HIV/AIDS Vaccine Symposium at New York Academy of Sciences on May 19. |
|
|
May 17, 2010 |
945 |
| Turning the Page in HIV Prevention Research: An AIDS Vaccine is Possible -- AVAC Examines The Way Forward. |
|
|
May 17, 2010 |
1245 |
| IAVI Statement for World AIDS Vaccine Day. |
|
|
May 14, 2010 |
802 |
| Genetic Immunity Develops Unique Nanomedicine Formulation for DermaVir Therapeutic Vaccine for HIV/AIDS. |
|
|
May 13, 2010 |
461 |
| Statement of Anthony S. Fauci, M.D., Margaret I. Johnston, Ph.D., and Gary J. Nabel, M.D., Ph.D., National Institute of Allergy and Infectious Diseases, National Institutes of Health, on National HIV Vaccine Awareness Day, May 18, 2010. |
|
|
May 11, 2010 |
134 |
| Insights into a gene that helps some people fight HIV may revive the quest for vaccines against the deadly virus behind AIDS, said researchers at Harvard University and the Massachusetts Institute of Technology. |
|
|
May 10, 2010 |
346 |
| New Findings May Lead to Designing Effective AIDS Vaccine. |
|
|
May 7, 2010 |
1137 |
| Europe plots new bid to solve HIV vaccine challenge. |
Nuthall, Keith |
|
May 1, 2010 |
122 |
| Inovio Biomedical CEO to Present at 2010 BIO International Convention. |
|
|
Apr 30, 2010 |
945 |
| GeoVax Labs to Attend BIO International Convention May 3-6, 2010 in Chicago at McCormick Place; Exhibiting at Booth 1631 in Georgia Pavilion. |
|
|
Apr 29, 2010 |
988 |
| GeoVax Labs Issues Letter to Shareholders. |
|
|
Apr 27, 2010 |
1138 |
| Closing keynote: globalization and the diplomacy of science. |
Makhema, Joseph |
|
Apr 1, 2010 |
2573 |
| GeoVax Labs Granted Allowance By FDA to Start Phase 1 Clinical Trial For HIV/AIDS Therapeutic Vaccine. |
|
|
Mar 30, 2010 |
958 |
| Slowing down immune system's 'brakes' could perk up HIV vaccines' efficacy. |
|
|
Mar 27, 2010 |
421 |
| Clinical Trials for HIV Vaccines Now Using Social Media to Attract Trial Participants. |
|
|
Mar 26, 2010 |
768 |
| Argos Therapeutics Presents New Phase 2a Data on the Impact of Arcelis[TM] HIV Program on Viral Genetic Diversity. |
|
|
Mar 25, 2010 |
620 |
| Clinical Trials for HIV Vaccines Now Using Social Media to Attract Trial Participants. |
|
|
Mar 24, 2010 |
818 |
| Genetic Immunity Presents DermaVir at DNA Vaccines 2010 Conference - Unique Nanomedicine Formulation and Topical Administration of an HIV/AIDS Therapeutic Vaccine. |
|
Conference news |
Mar 2, 2010 |
448 |
| HIV immunology: what lessons can we learn from recent vaccine trials? |
Kelleher, Peter |
Report |
Mar 1, 2010 |
3244 |
| Cyto Pulse, the Karolinska Institute and the Swedish Institute for Infectious Disease Control Receive Phase I Clinical Trial Approval from the Swedish Medical Products Agency to Evaluate an HIV Vaccine in Healthy Volunteers. |
|
|
Feb 22, 2010 |
420 |
| David N. Cook joins IAVI as Chief Operating Officer. |
|
|
Feb 1, 2010 |
706 |
| NewsRx Publishes Encyclopedia of Vaccines, 2009: An encyK Resource for Parents, Patients & Professionals. |
|
|
Jan 27, 2010 |
752 |
| HIV prevention responsibilities in HIV vaccine trials: complexities facing South African researchers. |
Essack, Zaynab; Slack, Catherine; Koen, Jennifer; Gray, Glenda |
|
Jan 1, 2010 |
3332 |
| Scientist of Indian origin says AIDS vaccine in a decade. |
|
|
Dec 29, 2009 |
503 |
| Biological catch-22 prevents generation of HIV blocking antibodies. |
|
|
Dec 16, 2009 |
535 |
| Rabies vaccine offers hope for AIDS vaccine. |
|
|
Dec 15, 2009 |
263 |
| Preventive HIV vaccine acceptability and behavioral risk compensation among a random sample of high-risk adults in Los Angeles (La Voices). |
Newman, Peter A.; Lee, Sung-Jae; Duan, Naihua; Rudy, Ellen; Nakazono, Terry K.; Boscardin, John; Kak |
Survey |
Dec 1, 2009 |
4676 |
| Phase I Study of Preventive HIV Vaccine Shows Improved Immune Responses When the Vaccine is Delivered by Electrical Impulses. |
|
|
Nov 30, 2009 |
1314 |
| 'Breakthrough' Thai HIV vaccine trial controversy. |
Bateman, Chris |
Clinical report |
Nov 1, 2009 |
1528 |
| SA 'ideal site' to further Thai HIV vaccine research gains. |
Bateman, Chris |
Brief article |
Nov 1, 2009 |
204 |
| AIDS slipping off international funding agenda--Piot. |
Bateman, Chris |
Brief article |
Nov 1, 2009 |
230 |
| Argos Therapeutics Presents Positive Phase 2 Viral Load and Immune Response Data for Arcelis[TM] HIV Program at the AIDS Vaccine 2009 Conference. |
|
Conference news |
Oct 21, 2009 |
1053 |
| IN BRIEF. |
|
|
Oct 21, 2009 |
744 |
| Thai HIV Vaccine Hype: AHF Reiterates Calls for Independent Review of AIDS Vaccine Effort. |
|
|
Oct 20, 2009 |
294 |
| Inovio Biomedical and Its Collaborators Present Research and Clinical Data at AIDS Vaccine 2009 Conference. |
|
Conference news |
Oct 20, 2009 |
1076 |
| Two Leading Research Institutions Partner to Accelerate the Development of an AIDS Vaccine Candidate. |
|
|
Oct 16, 2009 |
702 |
| Inovio Biomedical Announces Initiation of HIV Clinical Trial for DNA Vaccine Delivered Using Electroporation. |
|
Clinical report |
Oct 15, 2009 |
1326 |
| Formatech, Inc. to Donate Services to Formulate and Fill GeoVax Labs, Inc. HIV/AIDS Vaccine under Its "Fillanthropy[TM] Program". |
|
|
Oct 15, 2009 |
900 |
| HIV vaccine regimen cuts infections by 31%. |
Sullivan, Michele G. |
|
Oct 15, 2009 |
553 |
| Argos Therapeutics to Present Positive Immune Response and Viral Load Data for Arcelis[TM] HIV Program at the AIDS Vaccine 2009 Conference. |
|
Conference news |
Oct 13, 2009 |
369 |
| Thai HIV Vaccine Hype Misrepresents Data; AHF Calls for Independent Review of AIDS Vaccine Effort. |
|
|
Oct 12, 2009 |
431 |
| SAAVI HIV vaccine trials--one small step for humankind. |
Ncayiyana, Daniel J. |
|
Oct 1, 2009 |
777 |
| Inovio Biomedical to Present at Vaccine 3rd Global Congress. |
|
|
Sep 28, 2009 |
757 |
| Hopes for new Aids vaccine. |
|
|
Sep 27, 2009 |
280 |
| Hopes for new Aids vaccine. |
|
|
Sep 26, 2009 |
280 |
| Editorial: Fighting AIDS. |
|
Editorial |
Sep 26, 2009 |
532 |
| New hope over Aids virus vaccine. |
|
|
Sep 25, 2009 |
214 |
| Hopes for new Aids vaccine. |
|
|
Sep 25, 2009 |
280 |
| School gets $24M; AIDS, diabetes study. |
|
|
Sep 25, 2009 |
369 |
| END OF AIDS? Vaccine cuts infection by a THIRD. |
|
|
Sep 25, 2009 |
504 |
| END OF AIDS? Vaccine cuts infection by a THIRD. |
|
|
Sep 25, 2009 |
516 |
| END OF AIDS? New double vaccine cuts HIV infection by a THIRD. |
|
|
Sep 25, 2009 |
512 |
| AIDS vaccine hope. |
|
|
Sep 25, 2009 |
275 |
| HIV Vaccine Study First to Show Some Effectiveness in Preventing HIV. |
|
|
Sep 24, 2009 |
756 |
| Prime-Boost Vaccine Study Shows Modest Effect in Preventing HIV. |
|
Clinical report |
Sep 24, 2009 |
779 |
| HIV Vaccine Regimen Demonstrates Modest Preventive Effect in Thailand Clinical Study. |
|
Clinical report |
Sep 24, 2009 |
139 |
| HIV vaccine trial stopped infection; researchers find. |
|
Brief article |
Sep 24, 2009 |
159 |
| AIDS vaccine hailed as 'historic milestone'. |
|
|
Sep 24, 2009 |
311 |
| Aids vaccine protects trial volunteers. |
|
|
Sep 24, 2009 |
147 |
| Hopes for Aids vaccine. |
|
|
Sep 24, 2009 |
147 |
| Hopes for new Aids vaccine. |
|
|
Sep 24, 2009 |
280 |
| Vaccine trial raises Aids hopes. |
|
|
Sep 24, 2009 |
520 |
| A world first: Vaccine helps prevent HIV infection. |
|
|
Sep 24, 2009 |
577 |
| Breakthrough AIDS vaccine prevents infection. |
|
|
Sep 23, 2009 |
480 |
| HIV vaccine comes closer to reality. |
|
|
Sep 22, 2009 |
360 |
| 2 new antibodies may pave way for powerful AIDS vaccine. |
|
|
Sep 4, 2009 |
553 |
| IAVI: Two New Antibodies Found to Cripple HIV. |
|
|
Sep 3, 2009 |
2104 |
| Predicting phenotype and emerging strains among Chlamydia trachomatis infections. |
Dean, Deborah; Bruno, William J.; Wan, Raymond; Gomes, Joao P.; Devignot, Stephanie; Mehari, Tigist; |
|
Sep 1, 2009 |
6253 |
| Dianne Stewart, Formerly of the Global Fund to Fight AIDS, Tuberculosis and Malaria, Joins IAVI as Vice President of Resource Development. |
|
|
Aug 19, 2009 |
599 |
| Inovio Biomedical to Present at Novel Vaccines: Design & Development. |
|
|
Aug 12, 2009 |
685 |
| New strategies proposed for AIDS vaccine research. |
|
|
Aug 8, 2009 |
465 |
| AIDS vaccine funding down 10% in 2008. |
Alcorn, Keith |
|
Aug 1, 2009 |
603 |
| College students who feel 'invincible' unlikely to get HIV vaccine. |
|
|
Jul 30, 2009 |
329 |
| Abbott Laboratories Inc. |
|
Brief article |
Jul 13, 2009 |
240 |
| ON THIS DAY. |
|
|
Jul 11, 2009 |
189 |
| HIV-1 destroys immune response in the gut within days of infection. |
|
|
Jul 7, 2009 |
444 |
| IAVI and Theraclone Expand HIV Antibody Discovery Collaboration. |
|
|
Jul 6, 2009 |
741 |
| Letter from the co-executive director. |
Simmons, Paul |
Report |
Jun 22, 2009 |
365 |
| Back to basics (but not too far back) with vaccine research: an interview with Anthony S. Fauci, MD. |
Mascolini, Mark |
Interview |
Jun 22, 2009 |
1419 |
| Scientists devise new strategy to design antibody-based HIV vaccine. |
|
|
Jun 15, 2009 |
384 |
| ImmunoVaccine Technologies Partners With FIT Biotech to Advance a Therapeutic HIV Vaccine. |
|
|
May 26, 2009 |
504 |
| New approach may pave way for effective HIV vaccine. |
|
|
May 23, 2009 |
410 |
| Biotech Leaders, Patient Advocates Highlight Cutting-Edge HIV/AIDS Therapies, Need for Next Generation Treatments. |
|
|
May 19, 2009 |
1006 |
| New approach may pave way for effective HIV vaccine. |
|
|
May 18, 2009 |
410 |
| New Advances on the Long Road to the Development of an AIDS Vaccine. |
|
|
May 15, 2009 |
720 |
| Statement of Anthony S. Fauci, M.D., Director, National Institute of Allergy and Infectious Diseases, National Institutes of Health, on HIV Vaccine Awareness Day, May 18, 2009. |
|
|
May 15, 2009 |
89 |
| Leading Vaccine Discovery Expert Joins the International AIDS Vaccine Initiative (IAVI). |
|
|
May 5, 2009 |
779 |
| GeoVax signs HIV/AIDS vaccine proposal with health and hospital system of Cook County, Illinois. |
|
Company overview |
May 1, 2009 |
880 |
| Why decades-long AIDS vaccine search hasn't been fruitful. |
|
|
Apr 23, 2009 |
688 |
| vital: Now Aids vaccine is closer. |
|
|
Mar 16, 2009 |
355 |
| Natural antibodies may pave way for effective HIV vaccine. |
|
|
Mar 16, 2009 |
557 |
| Scientists make breakthrough in developing AIDS vaccine. |
|
|
Mar 13, 2009 |
461 |
| Scientists have found a new way to make the human immune system react instantly against foreign invaders, including cancer, instead of the weeks or months that vaccines now take. |
|
Report |
Mar 9, 2009 |
386 |
| HIV rapidly adapts to counter immune attack-controlling human genes. |
|
|
Feb 26, 2009 |
393 |
| Bioject Enters into a Collaborative Research Agreement with IAVI for the Delivery of an HIV Vaccine Candidate. |
|
|
Feb 24, 2009 |
654 |
| VGX Pharmaceuticals Proprietary DNA Vaccines Delivered with Electroporation Achieve Immune Responses Superior to Recombinant Adenovirus Serotype 5 (Ad5) Vectors. |
|
|
Feb 18, 2009 |
600 |
| Massachusetts General Hospital, the Massachusetts Institute of Technology and Harvard University formed an institute with a $100 million gift to find a vaccine against the AIDS virus. |
|
Brief article |
Feb 9, 2009 |
234 |
| Standard & Poor's Initiates Factual Stock Report Coverage on GeoVax Labs, Inc. |
|
|
Feb 5, 2009 |
618 |
| Omnia Biologics and Sumagen Announce Successful Manufacture of HIV/AIDS Vaccine Phase I Material. |
|
|
Feb 4, 2009 |
314 |
| IAVI and Algonomics to Collaborate on HIV Protein Design Project. |
|
|
Jan 26, 2009 |
964 |
| Profectus BioSciences Awarded $21.6 Million in NIH Contracts to Develop a HIV Preventative and a HIV Therapeutic Vaccine. |
|
|
Dec 8, 2008 |
584 |
| ADDING MULTIMEDIA GeoVax Labs and VGX International Announce Agreement at the Las Vegas "International Society of DNA Vaccines" Conference. |
|
Conference notes |
Dec 8, 2008 |
961 |
| HIV vaccine may be developed in five years, says Nobel Prize laureate. |
|
|
Dec 7, 2008 |
165 |
| IAVI Launches Video Commitments Project on World AIDS Day 2008. |
|
|
Dec 1, 2008 |
590 |
| Gilead Science Inc.'s. |
|
Brief article |
Nov 17, 2008 |
255 |
| New York City's Mayor Bloomberg and Other Honorees Herald the Opening of the Only Laboratory Devoted Solely to AIDS Vaccine Design and Development. |
|
Company overview |
Nov 12, 2008 |
1309 |
| Profectus BioSciences Executes an Assignment and License Agreement with Wyeth for Vaccines against HIV, HCV, HPV and HSV. |
|
|
Nov 10, 2008 |
351 |
| Centre Hospitalier Universitaire Vaudois, Swiss Vaccine Research Institute and Institut Genetique Moleculaire Montpellier: Study Sheds Light on the Mechanisms of Increased Risk of HIV Infection in the Step HIV Vaccine Trial. |
|
|
Nov 3, 2008 |
659 |
| Preliminary Phase I Safety Data for Preventive HIV Vaccine Delivered by Ichor's TriGrid to be Presented at AIDS Conference. |
|
|
Oct 17, 2008 |
1084 |
| VGX Pharmaceuticals Presents Non-Human Primate Study Data at AIDS Vaccine 2008 Conference. |
|
Conference news |
Oct 15, 2008 |
596 |
| Stakeholders regroup after failure of latest AIDS vaccine. |
London, Susan |
|
Oct 15, 2008 |
801 |
| Philadelphia story: 93% finish HIV vaccine trial. |
London, Susan |
|
Oct 15, 2008 |
608 |
| GenVec Receives Third-Year Funding from NIAID for HIV Vaccine Contract. |
|
|
Oct 2, 2008 |
512 |
| VGX Pharmaceuticals Awarded $23.5 Million NIH Contract to Develop DNA-Based Preventive HIV Vaccine Delivered Via Electroporation. |
|
|
Oct 1, 2008 |
612 |
| Researchers rebound from latest AIDS vaccine failure. |
London, Susan |
|
Oct 1, 2008 |
663 |
| Gilead Sciences Inc. |
|
Brief article |
Sep 8, 2008 |
143 |
| Maxygen Receives $3.4 Million Government Grant to Develop Vaccine Discovery Technology. |
|
|
Aug 27, 2008 |
1080 |
| Inovio Biomedical Expands In Vivo Electroporation License with International AIDS Vaccine Initiative for HIV Vaccine Research. |
|
|
Aug 14, 2008 |
1080 |
| AIDS may be curable, preventable by 2031, top Scientist says. |
|
|
Aug 11, 2008 |
443 |
| Mexico City AIDS 2008: Luminaries Call For Ending AIDS through A Vaccine at Global Conference. |
|
Conference news |
Aug 7, 2008 |
1221 |
| Resetting Expectations in the Search for an AIDS Vaccine. |
|
|
Aug 5, 2008 |
1316 |
| Glaxo says therapeutic vaccines hold big promise. |
|
|
Aug 4, 2008 |
348 |
| AIDS Vaccines: Where Do We Go From Here? |
|
|
Jul 28, 2008 |
412 |
| GeoVax Partners with Vivalis for Use of Its Revolutionary EBx(R) Technology to Manufacture Its MVA HIV/AIDS Vaccine. |
|
|
Jul 22, 2008 |
1745 |
| NIAID Will Not Move Forward With The Pave 100 HIV Vaccine Trial. |
|
|
Jul 17, 2008 |
144 |
| Diagnostic HYBRIDS Receives Third Frontier Grant for Development of Assays to Monitor Drug Resistance and Vaccine Production. |
|
|
Jun 27, 2008 |
947 |
| NIAID Creates HIV Vaccine Discovery Branch to Promote Synergy between Basic HIV Researchers and Vaccine Designers. |
|
|
Jun 25, 2008 |
116 |
| A dose of reality: revisiting pharmaceutical manufacturer liability for an HIV vaccine. |
Eisele, Erik Volker Ernst |
|
Jun 22, 2008 |
14899 |
| Search for an HIV Vaccine Continues Despite Setbacks. |
|
|
Jun 3, 2008 |
369 |
| Preparedness for AIDS vaccine trials in India. |
Excler, Jean-Louis; Kochhar, Sonali; Kapoor, Sushma; Das, Sweta; Bahri, Jyoti; Ghosh, Meenakshi Datt |
Report |
Jun 1, 2008 |
5349 |
| Bavarian Nordic Enters Clinical Trials With HIV Multiantigen Vaccine. |
|
|
May 27, 2008 |
417 |
| Bavarian Nordic Enters Clinical Trials with HIV Multiantigen Vaccine. |
|
|
May 27, 2008 |
452 |
| NIAID to Advance B-Cell Approach to HIV Vaccines. |
|
|
May 20, 2008 |
115 |
| Statement of Anthony S. Fauci, M.D., Director, National Institute of Allergy and Infectious Diseases, on HIV Vaccine Awareness Day, May 18, 2008. |
|
|
May 16, 2008 |
112 |
| Lack of circumcision tied to HIV vaccine failure. |
|
|
May 15, 2008 |
503 |
| MEDICAL MEMOS. |
|
|
Apr 28, 2008 |
132 |
| Scientific Consensus on AIDS Vaccine Prospect is Bleak, Poll Reveals. |
|
|
Apr 25, 2008 |
712 |
| NanoViricides to Begin HIV Animal Trials. |
|
|
Mar 27, 2008 |
541 |
| Teleconference: AHF to Call for Halt to HIV Vaccine Funding. |
|
|
Mar 24, 2008 |
294 |
| HIV Vaccine Funding: 'Enough is Enough,' Says AHF in Baltimore Sun. |
|
|
Mar 23, 2008 |
1133 |
| Participants in HIV vaccine trials may experience negative social effects. |
Hollander, D. |
Clinical report |
Mar 1, 2008 |
1056 |
| Monogram HIV Antibody Assay Is Key Component of Innovative Vaccine Development Program. |
|
|
Mar 1, 2008 |
497 |
| Challenges for intellectual property management of HIV vaccine-related research and development. |
Knowles, Lori; Bubela, Tania |
|
Jan 1, 2008 |
15500 |
| Challenges for intellectual property management of HIV vaccine-related research and development. |
Patten, San; Bubela, Tania; Knowles, Lori |
|
Jan 1, 2008 |
17818 |
| Creation of the Swiss Institute for Vaccine Research in Lausanne, Switzerland. |
|
|
Dec 5, 2007 |
478 |
| Inside the HIV fight: from vaccines to microbicides, from preexposure prophylaxis to circumcision, researchers are considering multiple options in the fight to prevent HIV. Tim Murphy talks to the players involved and gives us a progress report. |
Murphy, Tim |
|
Dec 4, 2007 |
2103 |
| AIDS Vaccine Failures Highlight Need to Focus on Lifesaving Treatment, Says AHF. |
|
|
Nov 16, 2007 |
497 |
| STEP Study Volunteers to be Informed Whether They Received Vaccine or Placebo. |
|
|
Nov 13, 2007 |
688 |
| Data from STEP Study Presented at Open Scientific Session Confirm Merck's Investigational HIV Vaccine was not Effective. |
|
|
Nov 7, 2007 |
3273 |
| Bavarian Nordic Vaccine Programs Progressing as Planned. |
|
|
Nov 6, 2007 |
1075 |
| AIDS vaccine development: challenges and opportunities. |
Chen, Robert T. |
|
Nov 1, 2007 |
545 |
| U.S. AWARDS $15 MIL TO GEOVAX HIV/AIDS VACCINE PROGRAM. |
|
|
Nov 1, 2007 |
521 |
| Ichor Medical Systems' TriGrid Selected as Delivery Platform in Collaboration to Test Preventative HIV Vaccine. |
|
|
Oct 1, 2007 |
897 |
| ENCOURAGING PHASE II DATA ON GENVEC HIV VACCINE. |
|
|
Oct 1, 2007 |
322 |
| United States awards $15 million grant to GeoVax' HIV/AIDS vaccine program. |
|
|
Oct 1, 2007 |
504 |
| DIGEST. |
|
|
Sep 27, 2007 |
176 |
| Vaccination and Enrollment Are Discontinued in Phase II Trials of Merck's Investigational HIV Vaccine Candidate. |
|
|
Sep 21, 2007 |
1681 |
| Bavarian Nordic Strengthens its Commercial Organisation and Updates on Pipeline Progress. |
|
|
Sep 19, 2007 |
944 |
| Etubics Awarded Grant from the National Institute of Health for Continued Development of HIV Vaccine. |
|
|
Aug 23, 2007 |
641 |
| Encouraging Phase II Data on HIV Vaccine Utilizing GenVec Technologies Presented at Seattle AIDS Conference. |
|
Conference news |
Aug 23, 2007 |
551 |
| Etubics Reports Breakthrough Next Generation HIV Vaccine at AIDS Conference. |
|
Conference news |
Aug 21, 2007 |
863 |
| Inovio Biomedical Establishes Agreements with National Cancer Institute and International Aids Vaccine Initiative to Conduct Research Using Inovio's DNA Delivery Technology. |
|
|
Jul 24, 2007 |
1323 |
| AIDS initiative signs first lease at bioscience center. |
|
|
Jul 11, 2007 |
338 |
| New data on Gardasil[R]. |
Heller, Marissa |
Brief article |
Jul 1, 2007 |
163 |
| Roche recalls Viracept due to chemical impurity. |
|
Brief article |
Jul 1, 2007 |
193 |
| First Ad35-Based HIV-1 Vaccine Enters Phase I Clinical Trial at the NIH. |
|
|
Jun 21, 2007 |
699 |
| Spanish Government Contributes 1 Million Euro for AIDS Vaccine Development. |
|
|
Jun 14, 2007 |
718 |
| Ethical-legal challenges in adolescent HIV vaccine trials. |
Slack, Catherine; Strode, Ann; Mamashela, Mothokoa |
|
Jun 1, 2007 |
1966 |
| Adolescents and HIV vaccine trials. |
Gray, G.; de Bruyn, G. |
Report |
Jun 1, 2007 |
1849 |
| Recruitment and sexual risk assessment of HIV-negative adolescents aged 14-17 years in preparation for HIV vaccine trials. |
Jaspan, Heather; Mark, Daniella; Myer, Landon; Flisher, Alan; Mathews, Catherine; Soka, Nosiphiwo; M |
|
Jun 1, 2007 |
823 |
| U.S. Developments Enhance Bavarian Nordic's Strategic Position. |
|
|
May 2, 2007 |
1316 |
| Prostitutes test AIDS vaccine. |
|
|
Apr 1, 2007 |
207 |
| AIDS Vaccine Advocacy Coalition Calls for Strategic Leadership and Urgency in the Implementation of Male Circumcision for HIV Prevention. |
|
|
Mar 28, 2007 |
629 |
| From the editor. |
Bekker, Linda-Gail |
Brief article |
Mar 22, 2007 |
322 |
| Cerus Corporation Awarded Grants for Its Listeria-Based Vaccine Platforms. |
|
|
Mar 5, 2007 |
738 |
| First large-scale HIV vaccine study starts in South Africa. |
|
Brief article |
Mar 1, 2007 |
241 |
| Inovio Biomedical DNA Delivery Technology Presented by Wyeth Researcher at Vaccine Conference. |
|
|
Feb 16, 2007 |
700 |
| AVAC Applauds Commencement of First HIV Vaccine Efficacy Trial in Africa. |
|
|
Feb 8, 2007 |
544 |
| HIV controllers: an untapped source of clues to overcoming HIV infection. |
Walker, Bruce D. |
|
Jan 1, 2007 |
966 |
| HIV vaccines: the future looks promising. |
Lewis, Dorothy E. |
|
Jan 1, 2007 |
1849 |
| CytoGenix synDNA(TM) HIV Vaccine Shows Robust Cellular Immune Response in Monkeys. |
|
|
Dec 12, 2006 |
599 |
| CytoGenix synDNA(TM) HIV Vaccine Shows Robust Cellular Immune Response in Monkeys. |
|
|
Dec 11, 2006 |
599 |
| European Governments Invest an Additional euro 26 Million in AIDS Vaccine Development. |
|
|
Dec 1, 2006 |
679 |
| The European and Developing Countries Clinical Trials Partnership (EDCTP) and the Bill & Melinda Gates Foundation Launch a 20 M Euro Call to Develop HIV Vaccine Trial Capacity in Africa. |
|
|
Nov 30, 2006 |
427 |
| GenVec HIV Vaccine Program to Receive Additional Funding. |
|
|
Oct 10, 2006 |
577 |
| GenVec Announces New $52 Million Contract with NIH/NIAID Vaccine Research Center to Support HIV Vaccine Production. |
|
|
Oct 5, 2006 |
585 |
| GENVAC VACCINE ENTERS HIV HUMAN THERAPEUTIC CLINICAL TRIALS. |
|
|
Oct 1, 2006 |
438 |
